Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Molecular Innate Immunity
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1463651
This article is part of the Research Topic Community Series in the Role of Complement in Health and Disease: Volume II View all 7 articles

Clinical associations of complement-activating collectins, collectin-10, collectin-11 and mannose-binding lectin in preterm neonates

Provisionally accepted
  • 1 Laboratory of Immunobiology of Infections, Institute for Medical Biology, Polish Academy of Sciences, Łódź, Poland
  • 2 Department of Cancer and Inflammation Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Region of Southern Denmark, Denmark
  • 3 Department of Perinatology, First Chair of Gynecology and Obstetrics, Medical University of Łódź, Łódź, Poland
  • 4 Department of Neonatology, Medical University of Gdańsk, Gdańsk, Poland
  • 5 II Department of Neonatology, Poznań University of Medical Sciences, Poznań, Poland
  • 6 Department of Neonatology, Poznań University of Medical Sciences, Poznań, Poland
  • 7 Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Capital Region of Denmark, Denmark

The final, formatted version of the article will be published soon.

    Introduction: Premature and low-birthweight infants are at especially high risk of perinatal complications, including impaired thermoregulation, infections and respiratory distress. Such adverse effects and the need for invasive procedures are associated with high mortality among preterms. This study focused on the influence of the innate immune system and tested the levels of collectins, collectin-10 (CL-10), collectin-11 (CL-11) and mannose-binding lectin (MBL) in preterm neonates.Methods: Cord blood was collected from 535 preterms (born at gestational age ≤37 weeks). COLEC10 and COLEC11 polymorphisms were analysed by real-time PCR and those of MBL2 by PCR/PCR-RFLP. The concentrations of collectins in sera from cord blood were determined with ELISA.Findings: Low concentrations of CL-10 in cord sera (<462 ng/ml corresponding to the 10 th percentile) were significantly associated with births at GA ≤32 weeks. Median levels of both CL-10 and CL-11 were significantly lower in preterms with very low birthweight (<1500 g), low Apgar 1' score and those who needed prolonged hospitalisation. Lower median CL-10 was also observed in fetal growth restriction cases. An important finding was the decreased concentrations of CL-10, CL- 11 and MBL in respiratory distress syndrome (RDS). For CL-10 and CL-11, that relationship was confined to infants born at GA ≥33 weeks and/or with body mass at birth ≥1500 g. Only CL-10 was found to influence susceptibility to early-onset infections. COLEC11 heterozygosity for the activitydecreasing polymorphism (rs7567833, +39618 A>G, His219Arg) was more common in preterm premature rupture of membranes (pPROM) cases, compared with corresponding reference groups. Furthermore, C/T or T/T genotypes at COLEC11 at rs3820897 (-9570 C>T) as well as MBL deficiency-associated MBL2 gene variants were more common in preterms diagnosed with RDS than among unaffected newborns.The complement-activating collectins investigated here could be important for maintaining homeostasis in preterm neonates. Despite similar structure and specificity, MBL, CL-10 and CL-11 manifest a different spectrum of clinical associations.

    Keywords: CL-10, CL-11, collectin, complement, mannose-binding lectin (MBL), neonate, prematurity, Respiratory Distress Syndrome (RDS)

    Received: 12 Jul 2024; Accepted: 27 Sep 2024.

    Copyright: © 2024 Gajek, Hansen, Jarych, Kufelnicka-Babout, Swierzko, Kobiela, Szala-Poździej, Chojnacka, Sobczuk, Domżalska-Popadiuk, Mazela, Kalinka, Thiel and Cedzyński. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Anna S. Swierzko, Laboratory of Immunobiology of Infections, Institute for Medical Biology, Polish Academy of Sciences, Łódź, Poland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.